BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 27109894)

  • 1. Pharmacological treatment of hypertrophic cardiomyopathy: current practice and novel perspectives.
    Ammirati E; Contri R; Coppini R; Cecchi F; Frigerio M; Olivotto I
    Eur J Heart Fail; 2016 Sep; 18(9):1106-18. PubMed ID: 27109894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Heart failure associated with hypertrophic cardiomyopathy].
    Oka N; Ohmura H; Ueda T
    Nihon Rinsho; 2007 May; 65 Suppl 5():425-9. PubMed ID: 17569322
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hypertrophic cardiomyopathy (HCM). Surgical versus drug therapy].
    Schulte HD; Gramsch-Zabel H; Schwartzkopff B; Gams E
    Z Kardiol; 1999 Mar; 88(3):163-72. PubMed ID: 10355066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy of hypertrophic cardiomyopathy].
    Cecchi F; Olivotto I
    G Ital Cardiol; 1999 Oct; 29(10):1199-203. PubMed ID: 10546134
    [No Abstract]   [Full Text] [Related]  

  • 5. [Drug therapy of hypertrophic cardiomyopathy].
    Hartmann A; Kaltenbach M; Hopf R
    Fortschr Med; 1992 Sep; 110(27):485-8. PubMed ID: 1358773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Medical treatment for cardiomyopathies].
    Suwa M
    Nihon Rinsho; 2000 Jan; 58(1):59-63. PubMed ID: 10885289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertension and concurrent arrhythmias.
    Lombardi F; Terranova P
    Curr Pharm Des; 2003; 9(21):1703-13. PubMed ID: 12871203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Pharmacotherapy in Hypertrophic Cardiomyopathy.
    Andries G; Yandrapalli S; Naidu SS; Panza JA
    Cardiol Rev; 2018; 26(5):239-244. PubMed ID: 29746257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug treatment for hypertrophic cardiomyopathy].
    Gibelin P
    Presse Med; 2009 Jun; 38(6):1001-4. PubMed ID: 19446431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Pharmacotherapy for Hypertrophic Cardiomyopathy.
    Wong TC; Martinez M
    Cardiol Clin; 2019 Feb; 37(1):113-117. PubMed ID: 30447712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current medical therapy for advanced heart failure.
    Gheorghiade M; Cody RJ; Francis GS; McKenna WJ; Young JB; Bonow RO
    Am Heart J; 1998 Jun; 135(6 Pt 2 Su):S231-48. PubMed ID: 9630088
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prognosis of hypertrophic and dilated cardiomyopathy].
    Ikeda H; Imaizumi T
    Nihon Rinsho; 2000 Jan; 58(1):86-92. PubMed ID: 10885294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved Cardiac Performance and Decreased Arrhythmia in Hypertrophic Cardiomyopathy With Non-β-Blocking R-Enantiomer Carvedilol.
    Seo K; Yamamoto Y; Kirillova A; Kawana M; Yadav S; Huang Y; Wang Q; Lane KV; Pruitt BL; Perez MV; Bernstein D; Wu JC; Wheeler MT; Parikh VN; Ashley EA
    Circulation; 2023 Nov; 148(21):1691-1704. PubMed ID: 37850394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological treatment options for hypertrophic cardiomyopathy: high time for evidence.
    Spoladore R; Maron MS; D'Amato R; Camici PG; Olivotto I
    Eur Heart J; 2012 Jul; 33(14):1724-33. PubMed ID: 22719025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in medical treatment of hypertrophic cardiomyopathy.
    Hamada M; Ikeda S; Shigematsu Y
    J Cardiol; 2014 Jul; 64(1):1-10. PubMed ID: 24735741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that pharmacological strategies lack efficacy for the prevention of sudden death in hypertrophic cardiomyopathy.
    Melacini P; Maron BJ; Bobbo F; Basso C; Tokajuk B; Zucchetto M; Thiene G; Iliceto S
    Heart; 2007 Jun; 93(6):708-10. PubMed ID: 17502652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical practice. Hypertrophic obstructive cardiomyopathy.
    Nishimura RA; Holmes DR
    N Engl J Med; 2004 Mar; 350(13):1320-7. PubMed ID: 15044643
    [No Abstract]   [Full Text] [Related]  

  • 18. Outcomes in patients hospitalized for heart failure and chronic obstructive pulmonary disease: differences in clinical profile and treatment between 2002 and 2009.
    Staszewsky L; Cortesi L; Tettamanti M; Dal Bo GA; Fortino I; Bortolotti A; Merlino L; Latini R; Roncaglioni MC; Baviera M
    Eur J Heart Fail; 2016 Jul; 18(7):840-8. PubMed ID: 27098360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current and emerging pharmacotherapy for the management of hypertrophic cardiomyopathy.
    Rosenzveig A; Garg N; Rao SJ; Kanwal AK; Kanwal A; Aronow WS; Martinez MW
    Expert Opin Pharmacother; 2023; 24(12):1349-1360. PubMed ID: 37272195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertrophic cardiomyopathy in childhood.
    Colan SD
    Heart Fail Clin; 2010 Oct; 6(4):433-44, vii-iii. PubMed ID: 20869644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.